Michelle LeRoux Williams insider trades: Osiris Therapeutics (OSIR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michelle reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 14, 2014 | OSIR | ↓ Sell | 61,934 | $14.09 | $873K | Direct | Mar 17, 2014 (3d) |
| Nov 15, 2013 | OSIR | ↓ Sell | 24,500 | $15.50 | $380K | Direct | Nov 18, 2013 (3d) |
| Dec 11, 2012 | OSIR | ↓ Sell | 520 | $9.31 | $5K | Direct | Dec 11, 2012 (0d) |
| Dec 11, 2012 | OSIR | ↑ Buy | 520 | $0.40 | $208 | Direct | Dec 11, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michelle LeRoux Williams's insider trades
Michelle LeRoux Williams is Chief Scientific Officer at Osiris Therapeutics (OSIR). Since Dec 11, 2012, Michelle has reported 1 open-market purchase worth $208 and 3 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (14 filings), shares withheld for taxes (11 filings), grants and awards (10 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OSIR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.